agilon health (NYSE:AGL – Free Report) had its price target reduced by Barclays from $5.00 to $2.00 in a research note published on Monday,Benzinga reports. They currently have an underweight rating on the stock.
Other research analysts have also issued research reports about the company. Citigroup reaffirmed a “sell” rating and set a $2.50 price target (down previously from $7.00) on shares of agilon health in a research report on Tuesday, October 29th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $8.00 price target on shares of agilon health in a research report on Wednesday, August 7th. Evercore ISI lowered their price target on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. Benchmark reaffirmed a “buy” rating and set a $9.00 price target on shares of agilon health in a research report on Thursday, August 8th. Finally, JMP Securities lowered agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday. Three investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $6.38.
Read Our Latest Stock Report on agilon health
agilon health Stock Performance
agilon health (NYSE:AGL – Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same period in the prior year, the firm earned ($0.06) earnings per share. As a group, equities research analysts predict that agilon health will post -0.35 EPS for the current fiscal year.
Insider Buying and Selling at agilon health
In other agilon health news, CEO Steven Sell bought 20,000 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were acquired at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the purchase, the chief executive officer now owns 67,590 shares in the company, valued at approximately $227,102.40. This trade represents a 42.03 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 3.20% of the company’s stock.
Institutional Trading of agilon health
Several institutional investors have recently added to or reduced their stakes in AGL. J.Safra Asset Management Corp boosted its stake in agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after purchasing an additional 3,625 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of agilon health in the 3rd quarter worth $28,000. City State Bank purchased a new position in shares of agilon health in the 3rd quarter worth $52,000. CWM LLC boosted its stake in shares of agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after buying an additional 7,288 shares during the last quarter. Finally, Nisa Investment Advisors LLC purchased a new position in shares of agilon health in the 2nd quarter worth $60,000.
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
See Also
- Five stocks we like better than agilon health
- How to Effectively Use the MarketBeat Ratings Screener
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- What is a Death Cross in Stocks?
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.